Navigation Links
Gentris Corporation Names New Chief Executive Officer
Date:6/21/2010

"xn-person">Sam Tetlow, Chairman of the Board of Gentris Corporation.  "It is a testament to his background, and to the organizations and individuals he has worked with previously, that Rick brings a world class set of values and capabilities to the Company.  Gentris has built a strong foundation and with Rick's leadership and external focus the Company is well positioned to accelerate its contribution to medicine and patient care."

Entering its second decade, Gentris collaborates with leading bio/pharma companies and academic researchers to ensure the successful clinical application of new advances in pharmacogenomics.  Gentris works with customers to create biomarker assays, define patient-responder recruitment criteria, and design protocols with improved end-points while reducing clinical trial costs and enhancing the probability of commercial success.  For example, Gentris validated IL28B as a novel biomarker to measure efficacy responses in new hepatitis C therapies.

"We are proud of the scientific, regulatory, and business accomplishments that Gentris has achieved during its first decade," said COO Dawn Bordeaux and CSO Scott Clark. "We look forward to new growth opportunities as Rick Williams assumes the position of chief executive officer."

Williams is an experienced executive who has been involved with a number of successful for-profit ventures (Merck, Genentech, Amerisource Bergen, and CellzDirect-Invitrogen) and non-profit organizations (The Hamner Institutes at RTP and North Carolina Biotechnology Center).  Early in his career, as Genentech's Director of Marketing and Health Economics, Williams helped to introduce biotechnology to the U.S. medical community and build the initial commercial platform at Genentech.  

"Genentech's suc
'/>"/>

SOURCE Gentris Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Clinical Logistics Enters Partnership with Gentris Corporation
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. CEL-SCI Corporation Releases Letter to Shareholders
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
7. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
8. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
11. Immunosyn Corporation Releases SF-1019 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Decision Resources Group,s ... about by the Affordable Care Act (ACA), ... of pharmaceutical therapies. The ACA altered how ... new regulations and expanded access via government-supported ... health exchanges—state-based marketplaces set up by states ...
(Date:7/31/2014)... LISBON, Portugal , July 31, 2014 ... Cork, Ireland has successfully passed a pre-approval ... The inspection, carried out by the FDA Consumer Safety ... initially planned, started on 21 st July and concluded ... to be compliant with the principles and guidelines of Good ...
(Date:7/31/2014)... announces the list of stocks featured in the Analyst Blog. ... news and events impacting stocks and the financial markets. Stocks ... - Free Report ), Gilead (Nasdaq: GILD - Free ... ), AbbVie (NYSE: ABBV - Free Report ) and ... Today, Zacks is promoting its ,Buy, stock recommendations. Get ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
... Pharmaceutical Corporation (OTC Bulletin Board: PRTT ) announced ... and patents-applications to Grunenthal GmbH, a German specialty pharmaceutical company ... The patent portfolio includes innovative pain drugs that address the ... Protect,s Chief Operating Officer, said, "We are very happy to ...
... NEW YORK, Feb. 9, 2011 Reportlinker.com ... is available in its catalogue: ... and Vulnerable Plaque Treatment 2011 ... report details the responses of a comprehensive ...
Cached Medicine Technology:Protect Pharma Sells Patent Portfolio to Grunenthal GmbH 2Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011 2
(Date:7/31/2014)... Steven Reinberg HealthDay ... -- Many obese and overweight kids don,t see themselves ... impossible, researchers report. In a new study, 27 ... than 3 percent overestimated it. About 25 percent of ... overestimated it, according to the study. "Efforts to ...
(Date:7/31/2014)... an algorithm aimed to diagnose pediatric patients with ... (CT) scans, without affecting diagnostic accuracy, Mayo Clinic ... recently published in the journal Surgery . ... of acute abdominal pain in children. Appendicitis occurs ... pus. CT scans are often used to diagnose ...
(Date:7/31/2014)... 2014 Joseph M. Lee, M.D., M.S., ... (CDHV), a leading provider of quality cardiovascular and internal ... Dr. Lee is a board certified cardiologist with ... In addition to his position at CDHV, Dr. Lee ... Hospital/ Columbia University Medical Center. Dr. Lee is board ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Millions of ... Some have had traumatic experiences as a child and ... dental work. As a highly experienced NJ cosmetic ... experience anxiety during their dental procedure. To help ... experienced team at Champagne Smiles offer several sedation dentistry ...
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular advancement ... a snorers airway to quiet snoring. , Dawn M. of ... with her husband by allowing them to share the same bedroom ... began about 15 years ago and I remember nights when it ... and had to head downstairs for any relief. As the years ...
Breaking Medicine News(10 mins):Health News:1 in 4 U.S. Kids Underestimate Their Weight, Study Finds 2Health News:1 in 4 U.S. Kids Underestimate Their Weight, Study Finds 3Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:Champagne Smiles is Thrilled to Now Offer Sedation Dentistry to their Patients 2Health News:New Snoring Mouthpiece Reviews from VitalSleep 2
... THURSDAY, April 5 (HealthDay News) -- More aggressive treatment ... (RA) is among the most important changes recommended in ... change is the result of emerging opinions that RA-related ... helps preserve patients, physical function, quality of life and ...
... economics behind the high U.S. teen birth rates, and ... rate of Massachusetts youth: high income inequality and low ... College economist Phillip B. Levine and University of Maryland ... to study the role that income inequality plays in ...
... at the Johns Hopkins Bloomberg School of Public Health and ... antibiotics previously banned by the U.S. government for poultry production ... March 21 in Environmental Science & Technology . ... Livable Future and ,Arizona State,s Biodesign Institute, looked for drugs ...
... Weill Cornell Medical College announced today the establishment of ... improve health and healthcare through informatics and technology. To ... Health Dr. Nirav R. Shah gave the keynote address. ... collaboration among a team of faculty from multiple departments ...
... 4 (HealthDay News) -- The U.S. Food and Drug Administration ... drug bevacizumab, most commonly known as Avastin, is being sold ... counterfeit product -- which the FDA says contains no active ... a Roche cancer medication that is approved for use in ...
... HealthDay Reporter , WEDNESDAY, April 4 (HealthDay News) ... being passed through generations, could play an important role ... Three research teams sequenced the genes of children with ... families, and compared the sequences with those of their ...
Cached Medicine News:Health News:Treat Rheumatoid Arthritis Early and Aggressively: Guidelines 2Health News:Wellesley study shows income inequality a key factor in high US teen births 2Health News:Researchers find evidence of banned antibiotics in poultry products 2Health News:Researchers find evidence of banned antibiotics in poultry products 3Health News:Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy 2Health News:Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy 3Health News:More Fake Avastin Found in U.S., FDA Says 2Health News:Researchers Find Gene Mutations That May Be a Key to Autism 2Health News:Researchers Find Gene Mutations That May Be a Key to Autism 3Health News:Researchers Find Gene Mutations That May Be a Key to Autism 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: